Microbiology data for patients with available intraperitoneal (IP) cultures from the index surgery (n=177 out of 554), according to whether they received empiric antifungals (AF) or not
| Total (n=177) | Empiric AF (n=95) | No empiric AF (n=82) | P value | |
| No growth | 29.4% (52/177) | 30.5% (29/95) | 28.0% (23/82) | |
| Candida spp | 42.9% (76/177) | 46.3% (44/95) | 39.0% (32/82) | 0.854 |
| In isolation | 32.8% (58/177) | 33.7% (32/95) | 31.7% (26/82) | |
| Escherichia coli | 1.1% (2/177) | 0.0% (0/95) | 2.4% (2/82) | |
| Enterobacter/Klebsiella | 6.2% (11/177) | 5.3% (5/95) | 7.3% (6/82) | |
| Pseudomonas | 0.6% (1/177) | 1.1% (1/92) | 0.0% (0/82) | |
| Streptococci | 7.3% (13/177) | 7.4% (7/95) | 7.3% (6/82) | |
| Enterococci | 2.3% (4/177) | 2.1% (2/95) | 2.4% (2/82) | |
| Staphylococci | 2.8% (5/177) | 2.1% (2/95) | 3.7% (3/82) | |
| Polymicrobial | 17.5% (31/177) | 17.9% (17/95) | 17.1% (14/82) | |
| Included Candida spp | 10.2% (18/177) | 12.6% (12/95) | 7.3% (6/82) |